Primary biliary cirrhosis and hepatic sarcoidosis – A case report

  • Tamara Alempijević Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Aleksandra Sokic-Milutinović Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Ljubiša Tončev Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia
  • Aleksandra Pavlović-Marković Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Srdjan Djuranovic Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Nada Tomanović Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Jelena Drulović Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Clinic for Neurology, Clinical Center of Serbia, Belgrade, Serbia
Keywords: liver cirrhosis, biliary, sarcoidosis, diagnosis, differential, histological techniques, treatment outcome,

Abstract


Introduction. Primary biliary cirrhosis (PBC) is an immune-mediated chronic progressive inflammatory liver disease leading to destruction of small interlobular bile ducts. Sarcoidosis is a chronic disorder of unknown etiology characterized by non-caseous granulomas. Case report. We reported a 69-year-old female patient with abdominal pain, malaise, vertigo, headaches, hands tremor and partial loss of hearing. Initial laboratory findings revealed elevated liver function tests and cholesterol with positive antimytochondrial and antinuclear antibodies. Liver biopsy revealed granuloma typical for PBC and granulomatous lesions typical for sarcoidosis. Elevated serum angiotensin-converting enzyme and granulomatous lesion on the brain magnetic resonance imaging (MRI) were detected and the patient was diagnosed with overlap of PBC and liver sarcoidosis and neurosarcoidosis. The patient was treated with ursodeoxicholic acid (UDCA) and prednisolone. Six months later the patient was symptom-free with laboratory findings within normal range. Conclusion. In PBC patients it is important to consider coexisting granulomatous liver diseases if elevated liver function tests persist despite UDCA therapy.

 

References

Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353(12): 1261−73.

Hohenester S, Oude-Elferink RP, Beuers U. Primary biliary cirrhosis. Semin Immunopathol 2009; 31(3): 283−307.

Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of pri-mary biliary cirrhosis. Semin Liver Dis 2002; 22(3): 291−302.

Yeaman SJ, Kirby JA, Jones DE. Autoreactive responses to pyru-vate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000; 174: 238−49.

Rajoriya N, Wotton CJ, Yeates DG, Travis SP, Goldacre MJ. Im-mune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J 2009; 85(2003): 233−7.

Tchernev G, Ananiev J, Cardoso JC, Wollina U, Verma SB, Patterson JW, et al. Sarcoidosis and molecular mimicry-important etiopa-thogenetic aspects: current state and future directions. Wien Klin Wochenschr 2012; 124(7−8): 227−38.

Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 2008; 29(3): 379−90.

Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol 2006; 5(4): 251−6.

Asvesti C, Hadziyannis SJ, Papadopoulos S, Giakoumoglou T, Hadzi-olou E, Trichia E, et al. Sweat gland carcinoma in a patient with sarcoidosis and primary biliary cirrhosis. Dermatology 1994; 189(2): 198−202.

Kishor S, Turner ML, Borg BB, Kleiner DE, Cowen EW. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol 2008; 58(2): 326−35.

Hughes P, McGavin CR. Sarcoidosis and primary biliary cirrhosis with co-existing myositis.Thorax 1997; 52(2): 201−2.

Sakamoto N, Ishimatsu Y, Kakugawa T, Hara A, Hara S, Amenomori M, et al. Sarcoidosis in a patient with systemic sclerosis and primary biliary cirrhosis. Intern Med 2010; 49(15): 1609−11.

Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103(12): 3184−92; quiz 3193.

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164(10 Pt 1): 1885−9.

Nolan JP, Klatskin G. The fever of sarcoidosis. Ann Intern Med 1964; 61: 455−61.

Kennedy PT, Zakaria N, Modawi SB, Papadopoulou AM, Murray-Lyon I, du Bois RM, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006; 18(7): 721−6.

Stanca CM, Fiel MI, Allina J, Caracta CF, Odin JA. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis 2005; 25(3): 364-70.

Bouros D, Snider GL. Primary Biliary Cirrhosis and Sarcoidosis. Chest 1989; 96(6): 1443.

Karlish AJ, Thompson RP, Williams R. A case of sarcoidosis and primary biliary cirrhosis. Lancet 1969; 2(7620): 599.

Maddrey WC, Sha E, Keeffe E. When sarcoidosis overlaps primary biliary cirrhosis. J Respir Dis 1985; 6: 41−5.

Stanley NM, Fox RA, Whimster WF, Sherlock S, James DC. Primary hiliary cirrhosis or sarcoidosis or both? N Engl J Med 1972; 287(25): 1282−4.

Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic chole-stasis of sarcoidosis. Am J Med 1975; 59(3): 373−87.

Fagan EA, Moore-Gillon JC, Turner-Warwick M . Multiorgan granulomas and mitochondrial antibodies. N EngI J Med 1983; 308(10): 572−75.

Published
2015/04/21
Section
Case report